title: Adjuvant treatment decisions for oropharyngeal cancer - is it time for a change?
authors.affiliation: Velindre Cancer Centre, Cardiff, UK. tomrackley@doctors.org.uk.
authors.forename: T
authors.initials: T
authors.lastname: Rackley
authors.forename: N
authors.initials: N
authors.lastname: Palaniappan
authors.forename: D
authors.initials: D
authors.lastname: Owens
authors.forename: M
authors.initials: M
authors.lastname: Evans
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D006801:Humans; D009959:Oropharyngeal Neoplasms / Q000401:mortality / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic
chemical_list: D002945:Cisplatin